Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
You are facing a test that will define you, the company, and potentially your freedom. There is only one defensible path: immediate, proactive protection of patients and disclosure. Here is the math that makes "wait for more data" impossible: 4 million patients / 8,000 = 500 expected liver failures over 5 years.Read the full answer
As CEO, I would not wait six months and I would not let the board delay disclosure while patients remain exposed to an unreported serious risk. I would treat this as a patient-safety, regulatory, legal, and trust crisis—not merely a financial-risk issue. My guiding decisions would be: Patient safety comes first.Read the full answer